Lincoln Pharmaceuticals Limited — Others, 05-04-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Lincoln Pharmaceuticals Ltd has announced a board meeting on the quarter and half-year financial results for the period ending March 31, 2025. The company has submitted a confirmation certificate from MUFG Intime India, its Registrar & Share Transfer Agent, regarding the dematerialisation of securities during this period, affirming that all received securities were properly processed and recorded.

This update indicates the company's continued compliance with procedural requirements, ensuring operational transparency. Investors may view this positively, as timely reporting supports investor confidence and reflects responsible governance. Overall, the outlook remains stable with no immediate risks noted.